Try our Advanced Search for more refined results

US Coverage

Law360 Authority | Deep News & Analysis

Global Coverage

Law360 Pulse | The Business of Law

Mealeys

MLex

June 23, 2014

VALLABHANENI v. ENDOCYTE, INC. et al

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. January 04, 2016

    Endocyte Dodges Class Action Over Cancer Drug Claims

    An Indiana federal judge on Monday quashed a securities class action claiming Endocyte Inc. lied about the effectiveness of a cancer drug tied to a $1 billion deal with Merck & Co. Inc. in order to inflate Endocyte's stock ahead of a public offering, saying the allegations cannot rest on a sole confidential witness.

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login